SYDNEY, Dec 13 (Reuters) - Australian biopharmaceutical giant CSL Ltd (CSL.AX) confirmed on Monday it is in talks to buy Swiss drugmaker Vifor Pharma Ltd (VIFN.S) in a deal reported by media to be worth about A$10 billion ($7.2 billion), as it looks to diversify beyond blood plasma products.
It's all over the news.
SYDNEY, Dec 13 (Reuters) - Australian biopharmaceutical giant...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.54 |
Change
-1.120(0.39%) |
Mkt cap ! $138.2B | |||
| Open | High | Low | Value | Volume |
| $285.50 | $285.86 | $282.18 | $110.7M | 388.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 368 | $285.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $285.54 | 425 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |